Parent Drug Name | Name of Impurity | Catalogue No. | |
---|---|---|---|
Selexipag | Selexipag DPA Des-Isopropyl Impurity | VL4020001 | View |
Selexipag | Selexipag DPB Desisopropyl Impurity | VL4020002 | View CAS 2514706-51-3 |
Selexipag | Selexipag Impurity B | VL4020005 | View CAS 18591-57-6 |
Selexipag | Selexipag In-house Impurity C | VL4020006 | View CAS 41270-66-0 |
Selexipag | Selexipag Metabolite N-Oxide | VE0011194 | View CAS 2732400-56-3 |
Selexipag | Selexipag Pyrazinone Impurity | VE0011192 | View CAS 18591-57-6 |
Selexipag | Selexipag TDA Impurity | VL4020004 | View CAS 162928-03-2 |
Selexipag | 2-Chloro-5, 6-diphenylpyrazine | VE0011193 | View CAS 41270-66-0 |
Selexipag | 4-[(5, 6-Diphenyl-2-pyrazinyl)(1-methylethyl)amino]-1-butanol | VE0010267 | View CAS 475086-75-0 |
Selexipag Related Compound
Selexipag is a medication used to treat the symptoms of pulmonary arterial hypertension, which is excessive blood pressure in the primary artery that transports blood from the right side of the heart (the ventricle) to the lungs.
References
- “Selexipag.” Nih.gov, National Institute of Diabetes and Digestive and Kidney Diseases, 10 Nov. 2016, www.ncbi.nlm.nih.gov/books/NBK548742/#:~:text=Introduction,pulmonary%20arterial%20hypertension%20(PAH). Accessed 9 Mar. 2023.
- “Selexipag Oral: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing – WebMD.” Webmd.com, 2023, www.webmd.com/drugs/2/drug-170740/selexipag-oral/details#:~:text=Selexipag%20is%20used%20to%20treat,the%20arteries%20in%20your%20lungs. Accessed 9 Mar. 2023.
- Simonneau, Gérald, et al. “Selexipag: An Oral, Selective Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension.” European Respiratory Journal, vol. 40, no. 4, Feb. 2012, pp. 874–80, https://doi.org/10.1183/09031936.00137511. Accessed 9 Mar. 2023.
FAQ
Does selexipag act as a vasodilator?
Selexipag is a prostacyclin receptor agonist that produces pulmonary vasodilation and is used to treat pulmonary arterial hypertension (PAH).
What purpose does selexipag serve?
Selexipag is used to treat pulmonary hypertension (pulmonary arterial hypertension-PAH). It is used to assist delay the progression of PAH and reduce the likelihood of hospitalization. Selexipag works by increasing the flow of blood through the arteries in your lungs.
Does selexipag contain prostacyclins?
Selexipag is an orally administered, selective prostacyclin receptor agonist used to treat pulmonary arterial hypertension.